Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFMOROCTOCOG ALFA vs ELACESTRANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFMOROCTOCOG ALFA vs ELACESTRANT: Safety Overview

Metric EFMOROCTOCOG ALFA ELACESTRANT
Total FAERS Reports 1,832 6,935
Deaths Reported 22 525
Death Rate 1.2% 7.6%
Hospitalizations 256 843
Average Patient Age 28.5 yrs 65.7 yrs
% Female Patients 1.9% 99.1%
FDA Approval Date N/A Jan 27, 2023
Manufacturer N/A Stemline Therapeutics, Inc.
Route N/A ORAL
Marketing Status N/A Prescription